GTR 105457897
Bids Are Invited For Formation Of Price Records For The Possible Supply Of Antineoplastic Medicines And Adjuvants - 29 Items (Sei 0040609437.000085/2025-10)
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
105457897
Tendering Authority
Subscribe to view
Tender No
4458/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Formation Of Price Records For The Possible Supply Of Antineoplastic Medicines And Adjuvants - 29 Items (Sei 0040609437.000085/2025-10)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
11-12-2025
Closed
Work Detail
(3547205) - Abiraterone, Acetate - Concentration/Dosage 250 Mg, Tablet Pharmaceutical Form, Oral Administration Route, (3097374) - Folinic Acid - Concentration/Dosage 3 Mg/Ml, Pharmaceutical Form Oral Solution, Vial Presentation Form, (3380637) - Zoledronic Acid - Concentration/Dosage 4 Mg, Pharmaceutical Form Lyophilized Powder For Injectable Solution, Presentation Form Vial-Ampule, Intravenous Administration Route, (3099040) - Anastrozole - Concentration/Dosage 1 Mg, Pharmaceutical Form Coated Tablet, (3074250) - Bicalutamide - Concentration/Dosage 50 Mg, 11/27/2025 - 12:11:37, (3108279) - Bleomycin, Sulfate - Concentration/Dosage 15 Iu, Parenteral Route Of Administration, (3244750) - Bortezomib - Concentration/Dosage 3.5 Mg, (3084345) - Capecitabine - Concentration/Dosage 500 Mg, (3110664) - Carboplatin - Concentration/Dosage 10 Mg/Ml, Pharmaceutical Form Injectable Solution, (3111172) - Carmustine - Concentration/Dosage 100 Mg, (3084078) - Cyclophosphamide - Concentration/Dosage 1 G, (3412652) - Cyclophosphamide - Concentration/Dosage 50 Mg, (3106870) - Cyproterone, Acetate - Concentration/Dosage 50 Mg, (3107078) - Cisplatin - Concentration/Dosage 1 Mg/Ml, (3383482) - Cytarabine - Concentration/Dosage 100 Mg/Ml, (3107418) - Cytarabine - Concentration/Dosage 50 Mg/Ml, (3241416) - Cladribine - Concentration/Dosage 1 Mg/Ml, (3160351) - Chlorambucil - Concentration/Dosage 2 Mg, (3109860) - Dacarbazine - Concentration/Dosage 200 Mg, (3242528) - Daunorubicin, Hydrochloride - Concentration/Dosage 20 Mg, Presentation Form Vial-Ampule + Diluent, (3372472) - Dexrazoxane - Concentration/Dosage 500 Mg, (3366251) - Docetaxel - Concentration/Dosage 80 Mg/2 Ml, (3160300) - Doxorubicin - Concentration/Dosage 50 Mg, (3531007) - Doxorubicin - Concentration/Dosage 2 Mg/Ml, Pharmaceutical Form Injectable Suspension, (3354911) - Epirubicin, Hydrochloride - Concentration/Dosage 2 Mg/Ml, Route Of Administration Intravenous Or Intravesical, (3166309) - Filgrastima - Concentration/Dosage 300 Mcg/Ml, (3458598) - Calcium Folinate - Concentration/Dosage 15 Mg, (3565041) - Calcium Folinate - Concentration/Dosage 50 Mg, Intravenous Or Intramuscular, (3196704) - Ondansetron, Ampoule Presentation Form
Key Value
Tender Value
5,143,373 - BRL
Tender Documents
Global Tender Document
e3689697-cd52-4439-93ad-347c1b00d9e3.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.